613 related articles for article (PubMed ID: 28484963)
21. Potential molecular targets of peroxynitrite in mediating blood-brain barrier damage and haemorrhagic transformation in acute ischaemic stroke with delayed tissue plasminogen activator treatment.
Chen H; Chen X; Luo Y; Shen J
Free Radic Res; 2018 Dec; 52(11-12):1220-1239. PubMed ID: 30468092
[TBL] [Abstract][Full Text] [Related]
22. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
Zhang Y; Wang Y; Zuo Z; Wang Z; Roy J; Hou Q; Tong E; Hoffmann A; Sperberg E; Bredno J; Berr SS; Xie M; Lee K; Wintermark M
J Neurol Sci; 2014 Dec; 347(1-2):148-54. PubMed ID: 25292413
[TBL] [Abstract][Full Text] [Related]
23. Neural stem cell therapy for subacute and chronic ischemic stroke.
Boese AC; Le QE; Pham D; Hamblin MH; Lee JP
Stem Cell Res Ther; 2018 Jun; 9(1):154. PubMed ID: 29895321
[TBL] [Abstract][Full Text] [Related]
24. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
[TBL] [Abstract][Full Text] [Related]
25. Visualizing the Distribution of Matrix Metalloproteinases in Ischemic Brain Using In Vivo
Huber VJ; Igarashi H; Ueki S; Terumitsu-Tsujita M; Nito C; Ohno K; Suzuki Y; Itoh K; Kwee IL; Nakada T
Contrast Media Mol Imaging; 2019; 2019():8908943. PubMed ID: 30723388
[TBL] [Abstract][Full Text] [Related]
26. Zinc contributes to acute cerebral ischemia-induced blood-brain barrier disruption.
Qi Z; Liang J; Pan R; Dong W; Shen J; Yang Y; Zhao Y; Shi W; Luo Y; Ji X; Liu KJ
Neurobiol Dis; 2016 Nov; 95():12-21. PubMed ID: 27388935
[TBL] [Abstract][Full Text] [Related]
27. tPA in the central nervous system: relations between tPA and cell surface LRPs.
Ortolano S; Spuch C
Recent Pat Endocr Metab Immune Drug Discov; 2013 Jan; 7(1):65-76. PubMed ID: 23231415
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment.
Knecht T; Story J; Liu J; Davis W; Borlongan CV; Dela Peña IC
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29257093
[TBL] [Abstract][Full Text] [Related]
29. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke.
Frankowski JC; DeMars KM; Ahmad AS; Hawkins KE; Yang C; Leclerc JL; Doré S; Candelario-Jalil E
Sci Rep; 2015 Dec; 5():17956. PubMed ID: 26648273
[TBL] [Abstract][Full Text] [Related]
30. Tight junction proteins related to blood-brain barrier and their regulatory signaling pathways in ischemic stroke.
Zheng X; Ren B; Gao Y
Biomed Pharmacother; 2023 Sep; 165():115272. PubMed ID: 37544283
[TBL] [Abstract][Full Text] [Related]
31. Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes.
Fan X; Jiang Y; Yu Z; Yuan J; Sun X; Xiang S; Lo EH; Wang X
Adv Pharmacol; 2014; 71():391-410. PubMed ID: 25307224
[TBL] [Abstract][Full Text] [Related]
32. Neurovascular unit transport responses to ischemia and common coexisting conditions: smoking and diabetes.
Sifat AE; Vaidya B; Villalba H; Albekairi TH; Abbruscato TJ
Am J Physiol Cell Physiol; 2019 Jan; 316(1):C2-C15. PubMed ID: 30207783
[TBL] [Abstract][Full Text] [Related]
33. Blood-Brain Barrier Damage in Ischemic Stroke and Its Regulation by Endothelial Mechanotransduction.
Nian K; Harding IC; Herman IM; Ebong EE
Front Physiol; 2020; 11():605398. PubMed ID: 33424628
[TBL] [Abstract][Full Text] [Related]
34. Acute hyperglycemia worsens ischemic stroke-induced brain damage via high mobility group box-1 in rats.
Huang J; Liu B; Yang C; Chen H; Eunice D; Yuan Z
Brain Res; 2013 Oct; 1535():148-55. PubMed ID: 24012767
[TBL] [Abstract][Full Text] [Related]
35. Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers.
Wang W; Li M; Chen Q; Wang J
Mol Neurobiol; 2015 Dec; 52(3):1572-1579. PubMed ID: 25367883
[TBL] [Abstract][Full Text] [Related]
36. Oxygen or cooling, to make a decision after acute ischemia stroke.
Liu WC; Jin XC
Med Gas Res; 2016; 6(4):206-211. PubMed ID: 28217292
[TBL] [Abstract][Full Text] [Related]
37. Antibody-mediated inhibition of tissue-type plasminogen activator binding to the low-density lipoprotein receptor-related protein 1 as a potential beneficial modulator for stroke therapy.
Klecker PH; Fritzen L; Mazura AD; Weggen S; Pietrzik CU
J Cell Biochem; 2023 Jul; 124(7):1040-1049. PubMed ID: 37288821
[TBL] [Abstract][Full Text] [Related]
38. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
39. Matrix Metalloproteinase-12 Induces Blood-Brain Barrier Damage After Focal Cerebral Ischemia.
Chelluboina B; Klopfenstein JD; Pinson DM; Wang DZ; Vemuganti R; Veeravalli KK
Stroke; 2015 Dec; 46(12):3523-31. PubMed ID: 26534974
[TBL] [Abstract][Full Text] [Related]
40. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
